Paediatric Research Society subsequent delay in motor milestones, and her 10-yearold sister with bilateral pes cavus and talipes equinovarus, otherwise symptom-free, who was also found to have facial weakness and EMG evidence of myotonia; two floppy infants with delayed milestones whose related mothers have a subclinical (almost) involvement; and a 6-year-old boy who presented with bilateral facial palsy and whose symptom-free mother and grandfather have EMG evidence of myotonia.
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The typical EMG pattern is readily missed, unless carefully searched for in distal as well as more proximal muscles. Muscle biopsy may be histologically normal in these children, but may show selective type 1 fibre atrophy with histochemical enzyme reactions. We have therefore investigated the possibility of a concomitant rise in erythrocytic DPG concentration.
The DPG level was higher in 20 subjects with primary trisomic Down's syndrome (12 males, 8 females, mean age 17-6 years, range 9 to 26 years; mean 5-37 ztmoles/ ml RBC; SD 0 625) than in 20 matched controls (mean 4 32 jtmoles/ml RBC; SD 0-368; P <0-001).
Changes in DPG concentration may be influenced by red cell pH and conditions of hypoxia as well as glycolytic activity. Anaemia was excluded in our patients (mean PCV = 43-1%; SD 3 4; mean Hb concentration 14-7 g/100 ml; SD 1 -498).
One Creatine phosphokinase is present in high concentration in brain as well as in skeletal and heart muscle.
Previous studies (Herschkowitz and Cumings, 1964; Nathan, 1967) have suggested increased CPK activity in a number of neurological diseases, particularly in patients with progressivehydrocephalus and symptomatic epilepsy. Sherwin, Norris, and Bulcke (1969) have shown that CSF contains only the brain isoenzyme of CPK.
In this study, which is part of a wider investigation of CSF-CPK in children with neurological disorders, all 65 children studied had a myelomeningocele and hydrocephalus. CPK was estimated, along with routine bacteriological and biochemical estimations, and pressure measurements taken whenever a ventricular tap was indicated clinically. CSF was withdrawn during the investigation and treatment of increased intracranial pressure, ventriculitis, and blocked shunts. Serum CPK levels were estimated concurrently in 11 cases.
The main findings were: (1) No correlation was found between serum and CSF levels of CPK, or between CSF-CPK and protein levels or pressure readings.
(2) Newborn infants with myelomeningocele have increased levels of CPK in CSF. (3) Increased CSF-CPK levels are also found in most cases of raised intracranial pressure and in ventriculitis where they tend to parallel the clinical course of the infection. (4) CPK levels in the myelomeningocele lesion fluid were much higher than those in ventricular CSF on concurrent specimens.
Thus there are indications that CSF-CPK determinations can be useful in the management of blocked or malfunctioning shunts but may not add additional information in the management of ventriculitis.
